Register for email alerts and news feeds:
This journal | BMJ Group
rss
Annals of the Rheumatic Diseases 1999;58:585-587; doi:10.1136/ard.58.9.585
Copyright © 1999 BMJ Publishing Group Ltd & European League Against Rheumatism.
Ann Rheum Dis 1999;58:585-587 ( September )

Concise report

Old drug, new tricks: haloperidol inhibits secretion of proinflammatory cytokines R J Mootsa, Z Al-Saffara, D Hutchinsona, S P Goldingb, S P Youngb, P A Baconb, P J McLaughlinc

a Rheumatology Research Group, University Hospital Aintree, Longmoor Lane, Liverpool L9 7AL, b Department of Rheumatology, Birmingham University, Birmingham, c Department of Immunology, University of Liverpool, Liverpool

Correspondence to: Dr R J Moots.

Accepted for publication 24 March 1999.

OBJECTIVES---It was noted that treatment of a patient with acute mania by haloperidol was associated with marked improvement in activity of rheumatoid arthritis. The objective of this study was to examine the effects of haloperidol on inflammatory cytokine release in vitro, as a potential mechanism to explain the in vivo anti-inflammatory effects of haloperidol.
METHODS---The effect of haloperidol on the production of inflammatory cytokines interleukin 1beta (IL1beta ) and tumour necrosis factor alpha  (TNFalpha ) was measured in bacterial lipopolysaccharide stimulated whole blood cultures and on the promonocyte cell line THP-1, using commercial and in house enzyme linked immunosorbent assays to measure cytokine concentrations.
RESULTS---Haloperidol inhibited lipopolysaccharide stimulated production of both IL1beta and TNFalpha in vitro in a dose dependent manner and over a prolonged time period. Marked inhibition was seen over a range of concentrations of haloperidol from 0.5 µg/ml to 50 µg/ml, including those predicted to occur in the patient's blood.
CONCLUSIONS---Haloperidol treatment seemed to alleviate inflammation in rheumatoid arthritis. In vitro experiments would suggest that the mechanism is by direct inhibition of proinflammatory cytokine release. This phenomenon requires further investigation and may potentially lead to the development of novel treatment.


© 1999 by Annals of the Rheumatic Diseases

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

BMJ Careers - Latest Rheumatology Jobs

Rheumatology Jobs